Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Technique effective option for managing flap complications
San Francisco-Transepithelial surface ablation with adjunctive mitomycin-C (Mutamycin, Bristol-Myers Oncology) is a useful technique for achieving good visual outcomes and preventing haze in patients whose LASIK procedure was aborted because of a flap complication, said Laura T. Muller, MD, at the American Society of Cataract and Refractive Surgery annual meeting.
Related Videos
Related Content
